Xuenong Ouyang

6.6k total citations
53 papers, 894 citations indexed

About

Xuenong Ouyang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuenong Ouyang has authored 53 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Molecular Biology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuenong Ouyang's work include Cancer-related gene regulation (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer-related molecular mechanisms research (7 papers). Xuenong Ouyang is often cited by papers focused on Cancer-related gene regulation (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer-related molecular mechanisms research (7 papers). Xuenong Ouyang collaborates with scholars based in China, United States and Hong Kong. Xuenong Ouyang's co-authors include Qian Huang, Fangwei Xie, S W Tsao, Y.C. Wong, Xiong Chen, Jie Li, Zhongquan Zhao, Yinghao Yu, Kun Li and Qiaojia Huang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xuenong Ouyang

51 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuenong Ouyang China 16 484 395 239 211 96 53 894
Timothy G. Whitsett United States 18 527 1.1× 247 0.6× 239 1.0× 266 1.3× 81 0.8× 35 996
Shunchang Jiao China 14 349 0.7× 398 1.0× 205 0.9× 207 1.0× 100 1.0× 35 781
Dong Hoon Shin South Korea 16 491 1.0× 271 0.7× 152 0.6× 311 1.5× 66 0.7× 40 830
Jinglei Qu China 19 611 1.3× 469 1.2× 213 0.9× 297 1.4× 183 1.9× 50 1.1k
Hae Hyun Jung South Korea 18 378 0.8× 293 0.7× 161 0.7× 330 1.6× 83 0.9× 30 772
Yoon‐Kyung Jeon South Korea 15 511 1.1× 323 0.8× 290 1.2× 285 1.4× 125 1.3× 16 904
Youngtae Jeong United States 11 504 1.0× 190 0.5× 154 0.6× 199 0.9× 93 1.0× 20 805
Juan Moreno‐Rubio Spain 19 634 1.3× 288 0.7× 162 0.7× 393 1.9× 86 0.9× 35 1.1k
Ana Sebio Spain 15 542 1.1× 512 1.3× 214 0.9× 177 0.8× 64 0.7× 67 980
Haihua Yuan China 18 611 1.3× 325 0.8× 167 0.7× 375 1.8× 85 0.9× 36 905

Countries citing papers authored by Xuenong Ouyang

Since Specialization
Citations

This map shows the geographic impact of Xuenong Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuenong Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuenong Ouyang more than expected).

Fields of papers citing papers by Xuenong Ouyang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuenong Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuenong Ouyang. The network helps show where Xuenong Ouyang may publish in the future.

Co-authorship network of co-authors of Xuenong Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuenong Ouyang. A scholar is included among the top collaborators of Xuenong Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuenong Ouyang. Xuenong Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Sun, Yuanjue, Yongqian Shu, Baorui Liu, et al.. (2016). A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy. Experimental and Therapeutic Medicine. 12(6). 4017–4024. 19 indexed citations
5.
Zhao, Zhongquan, et al.. (2016). Gefitinib induces lung cancer cell autophagy and apoptosis via blockade of the PI3K/AKT/mTOR pathway. Oncology Letters. 12(1). 63–68. 75 indexed citations
6.
Zheng, Jiawei, Shanshan Huang, Yu-Fang Huang, et al.. (2015). Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. Tumor Biology. 37(6). 7853–7859. 20 indexed citations
7.
Wang, Xiaoting, Fenghua Lan, Yinghao Yu, et al.. (2014). Prognostic value of differential CCND1 expression in patients with resected gastric adenocarcinoma. Medical Oncology. 32(1). 338–338. 15 indexed citations
8.
Chen, Xiong, et al.. (2014). [Advances of PD-1/PD-L1 signaling pathway in immune escape and treatment for 
non-small cell lung cancer].. SHILAP Revista de lepidopterología. 17(10). 734–40. 6 indexed citations
9.
Xie, Fangwei, Xi Chen, Xiong Chen, et al.. (2014). Influence of UGT1A1 gene methylation level in colorectal cancer cells on the sensitivity of the chemotherapy drug CPT-11. Biomedicine & Pharmacotherapy. 68(7). 825–831. 9 indexed citations
10.
Huang, Qiaojia, Fenghua Lan, Xiaoting Wang, et al.. (2014). IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9. Molecular Cancer. 13(1). 18–18. 119 indexed citations
11.
Xie, Fangwei, Xi Chen, Xiong Chen, et al.. (2013). Regulation and expression of aberrant methylation on irinotecan metabolic genes CES2, UGT1A1 and GUSB in the in-vitro cultured colorectal cancer cells. Biomedicine & Pharmacotherapy. 68(1). 31–37. 6 indexed citations
12.
Chen, Xi, Han Wang, Xuenong Ouyang, Fangwei Xie, & Jingjing Wu. (2013). Research on drug resistance mechanism of trastuzumab caused by the activation of PI3K/Akt signaling pathway. Współczesna Onkologia. 4(4). 363–369. 8 indexed citations
13.
Liu, Zhizhen, et al.. (2012). Applied research on serum protein fingerprints for prediction of Qi deficiency syndrome and phlegm and blood stasis in patients with non-small cell lung cancer. Journal of Traditional Chinese Medicine. 32(3). 350–354. 8 indexed citations
14.
Sun, Yuanjue, Baorui Liu, Ping Liu, et al.. (2012). A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine (ALC) in treatment of chemotherapy-induced peripheral neuropathy (CPIN).. Journal of Clinical Oncology. 30(15_suppl). 9017–9017. 6 indexed citations
15.
Huang, Qian & Xuenong Ouyang. (2011). Biochemical-markers for the diagnosis of bone metastasis: A clinical review. Cancer Epidemiology. 36(1). 94–98. 31 indexed citations
16.
Chen, Juan, et al.. (2010). Clinical significance of Her-2 protein expression in gastric cancer. World Chinese Journal of Digestology. 18(13). 1375–1375. 1 indexed citations
17.
Xie, Fangwei, Kun Li, & Xuenong Ouyang. (2009). Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients. Clinical & Experimental Metastasis. 26(8). 1025–1032. 47 indexed citations
18.
Chen, Wen, et al.. (2007). [Study on the relationship between vascular endothelial growth factor and syndrome type of traditional Chinese medicine in patients with gastric carcinoma].. PubMed. 27(2). 127–30. 6 indexed citations
19.
Chen, Xi, et al.. (2005). [Relationship between sCD44v6 expression and TCM differentiation type of gastric carcinoma patients and influence of weitai capsule on the expression].. PubMed. 25(1). 12–5. 1 indexed citations
20.
Ouyang, Xuenong, et al.. (2002). Over Expression of ID-1 in Prostate Cancer. The Journal of Urology. 167(6). 2598–2602. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy G. Whitsett Breakdown of academic impact, for papers by Shunchang Jiao Breakdown of academic impact, for papers by Dong Hoon Shin Breakdown of academic impact, for papers by Jinglei Qu Breakdown of academic impact, for papers by Hae Hyun Jung Breakdown of academic impact, for papers by Yoon‐Kyung Jeon Breakdown of academic impact, for papers by Youngtae Jeong Breakdown of academic impact, for papers by Juan Moreno‐Rubio Breakdown of academic impact, for papers by Ana Sebio Breakdown of academic impact, for papers by Haihua Yuan
Rankless by CCL
2026